SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Arbutus Biopharma
An SI Board Since February 2014
Posts SubjectMarks Bans Symbol
42 7 0 ABUS
Emcee:  donpat Type:  Moderated
Introduction Market Data Compact
Arbutus Biopharma Corporation is a biopharmaceutical company dedicated to discovering, developing and commercializing a cure for patients suffering from chronic HBV infection. Arbutus is headquartered in Vancouver, BC, and has facilities in Warminster, PA. For more information, visit
arbutusbio.com
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
42_____________________ FORM 8-K _____________________ CURRENT REPORT Pursuant donpat-9/22/2017
41investor.arbutusbio.comdonpat-12/12/2016
40Tekmira renamed Arbutus Biopharma Corporation (ABUS).donpat-8/3/2015
39Tekmira Pharmaceuticals Receives $28.75 Average PT from Analysts (NASDAQ:TKMR) donpat-5/7/2015
38Combatting Viruses with RNA-Targeted CRISPRScientists re-engineer a Cas9 enzyme donpat14/27/2015
37Cancer Drug Shows Promise for Treating Hepatitis B Mon, 04/20/2015 - 4:46pm Wadonpat14/21/2015
36Tekmira Pharmaceuticals Corp Price Target Update by Thomas Lindt on March 4, 20donpat-3/4/2015
35Gilead ( GILD) Agrees to a Discounted Price of $46,000 for Sovaldi in Europe 2donpat-2/13/2015
34Reasons for the Merger In evaluating the merger and the Merger Agreement, thdonpat-1/24/2015
33It was revealed in a filing yesterday with the U.S Securities and Exchange Commdonpat-1/21/2015
32The Company continues to see evidence of anti-tumor activity in some treated subdonpat-12/31/2014
31 Multifunctional RNA nanoparticles to combat cancer and viral infections Postedonpat-10/13/2014
30MARKET REPORT: Merger mania in healthcare sector keeps dealers on toes during pedonpat-8/27/2014
29Ebola declared a public-health emergency World Health Organization announcemendonpat-8/8/2014
28FDA switches course on Tekmira drug as Ebola panic triggers policy review [gradonpat-8/8/2014
27FDA Modifies Tekmira's TKM-Ebola Clinical Hold to Partial Hold PRESS RELEASdonpat-8/7/2014
26FDA Greenlights Use of TKM-EBOLA in Current Outbreak Thursday, August 7, 2014 donpat-8/7/2014
25Tekmira Pharmaceuticals Corp (TKMR) After Hours Trading TKMR $15.43 +1.16 +8.13donpat-8/7/2014
24Ebola Drug by Tekmira May Be Used on Infected Patients By Cynthia Koons, Caroldonpat-8/7/2014
23Human Ebola Virus Species and Compositions and Methods Thereof US 20120251502 Ascion-8/2/2014
22U.S. FDA says 'stands ready' to work with companies developing Ebola drudonpat-8/2/2014
21Ebola Experimental Treatments: Tekmira TKM-EBOLA, Mapp Biopharmaceuticals MB-003donpat-8/2/2014
20Tekmira shares skyrocket as Ebola outbreak intensifies in Africa Fri Aug 1, 20donpat-8/1/2014
19Tekmira Pharmaceuticals Now Covered by Clarus (TKMR) Posted by Seth Barnet on Adonpat-8/1/2014
18Ebola Virus Now Threatens 21 Million People In Major Metro Area Published on Judonpat-7/29/2014
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News